24-hour observation for patients with fainting episodes
Official title: Multicenter Randomized Clinical Trial to Assess the Clinical Benefit of 24-hour in Hospital Observation of Syncope Patients Admitted to the Cardiac Emergency Room
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06472375 · Data updated 2026-11-12
This study is testing if keeping patients with fainting episodes under observation for 24 hours can help doctors decide when it's safe for them to go home instead of sending them home right away.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 640 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 1 site (Amsterdam) |
| Status | Recruiting |
| Started | November 17, 2023 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2026 |
| Registry record updated | February 24, 2026 |
| Trial ID | NCT06472375 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults assessed as low- and intermediate-risk syncope patients.
✕Probably not a fit
Patients under 18 years old or those with serious co-existing conditions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of a 24-hour observation period with telemetry for low- and intermediate-risk syncope patients compared to immediate discharge. It will utilize a guideline-based syncope algorithm to identify eligible patients in a cardiac emergency room setting. The study seeks to clarify the optimal discharge timing for these patients, potentially reducing unnecessary hospital admissions. The findings will be supported by educational resources developed in collaboration with various Dutch medical societies.
Why it matters
Potential benefit: If successful, this study could lead to improved management and discharge protocols for syncope patients, enhancing patient care and resource utilization.
How similar studies have gone: While this specific approach has not been tested in a randomized controlled trial, the study builds on existing guidelines and practices in syncope management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: All patients that are assessed as low- and intermediate risk syncope, are eligible for inclusion in this trial. The initial syncope evaluation includes: 1. Complete and thorough history taking of the syncope event and past medical history 2. Physical examination including supine and standing BP measurement and 3. 12 lead ECG. Exclusion Criteria: A potential patient who meets any of the following criteria will be excluded from participation in this study: 1. Those aged \<18 years 2. Those in whom syncope / transient loss of consciousness co-exist with trauma or other serious condition identified in the CER (massive bleeding, pulmonary embolus) or any high-risk features upon assessment with guideline based SA 3. Those with any other conditions then syncope / transient loss of consciousness for which admission is required (including social indication for admission, etc.) 4. Contraindication for early discharge as the discretion of the responsible physician 5. Those with a learning disability 6. Those presenting with pre-syncope 7. Those who are unwilling to provide informed consent (those will be asked to be enrolled for the SYNCOPE R.I.S.C-registry)
Where it's running
-
Amsterdam UMC
Amsterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Frederik de Lange, MD PhD — Pi
- Study coordinator: Frederik de Lange, MD PhD
- Email: f.j.delange@amsterdamumc.nl
- Phone: +31 (0) 20 5669111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Whole-body bedside ultrasound in older adults after a fall
This study tests whether doing a full-body ultrasound at the bedside changes how doctors manage older adults (65+) who come to the emergency department after a fall.
-
Do medicines that lengthen the heart's QT interval cause serious heart problems in hospitalized adults?
This project will test whether commonly used hospital medicines that can prolong the heart's QT interval lead to serious cardiac events in adults admitted to Ontario hospitals.
-
AVEIR leadless pacemaker registry in the United Kingdom
This project will follow people in the UK who receive an AVEIR leadless pacemaker to see how well the device works and how safe it is over five years.
-
AI-based assessment of heart function using ECG wearable monitors
This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.
-
Evaluating the timing of syncope and asystole during tilt table testing
This study is testing if the timing of fainting during a tilt table test can help predict how well a pacemaker will work for people with reflex syncope.
-
Cardioneuroablation for treating bradycardia
This study is testing a new procedure called cardioneuroablation to see if it can help people with slow heart rates feel better without needing a permanent pacemaker.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.